Condition: Heart Valve Disease · Mitral Valve (MV) Regurgitation · Mitral Valve Disease · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
The objective of this study is to evaluate and predict the progression of moderate cardiac valve stenosis and regurgitation using clinical, biological, echocardiographic, computed tomography (CT), and magnetic resonance imaging (MRI) data. Additionally, the study aims to analyze the potential impact of device-based interventions, pharmacological therapy, and lifestyle modifications on disease progression.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Fujian Provincial Hospital, Affiliated to Fuzhou University | Fuzhou, Fujian, China | Recruiting |
| Renmin Hospital of Wuhan University | Wuhan, Hubei, China | Recruiting |
| Xiangya Hospital of Central South University | Changsha, Hunan, China | Recruiting |
| Second Xiangya Hospital of Central South University | Changsha, Hunan, China | Recruiting |
| The General Hospital of Northern Theater Command | Shenyang, Liaoning, China | Recruiting |
| The First Affiliated Hospital of Air Force Medicial University | Xi'an, Shaanxi, China | Recruiting |
| Affiliated Hospital of Qingdao University | Qingdao, Shandong, China | Recruiting |
| Huaxi Hospital | Chengdu, Sichuan, China | Recruiting |
| People's Hospital of Xinjiang Uygur Autonomous Region | Ürümqi, Xinjiang, China | Recruiting |
| Fuwai Yunnan Cardiovascular Hospital | Kunming, Yunnan, China | Recruiting |
| Second Affiliated Hospital of Zhejiang University, School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
| Chinese Academy of Medical Sciences, Fuwai Hospital | Beijing, China | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07267117